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Keratinocyte gangliosides in¯uence cellular func-
tions, including proliferation, adhesion, migration,
and differentiation. The effects of endogenous
depletion of membrane gangliosides by gene trans-
fection of a human ganglioside-speci®c sialidase on
cell survival were investigated. Ganglioside deple-
tion promotes survival of the human keratinocyte-
derived SCC12 cell line through upregulated phos-
phorylation of b1 integrin, and increased phos-
phorylation and activity of integrin-linked kinase,
protein kinase B/Akt, and Bad, with resultant
inhibition of caspase-9 activation. Ganglioside de®-
ciency also increases expression of cyclins D1 and
E, promoting cell cycle progression from G1 phase
to S phase. Inhibition of either protein kinase B/
Akt or integrin-linked kinase activity renders the
ganglioside-de®cient cells susceptible to triggers of
apoptosis. Both serine-473 and threonine-308 sites
of protein kinase B/Akt show increased phos-
phorylation in ganglioside-de®cient cells, but the
cell survival correlates with increased phosphoryl-
ation of the serine-473 site of Akt, not with
increased phosphorylation of the threonine-308
site. Consistently, blockade of ganglioside GT1b
function activates integrin-linked kinase and only
the serine-473 site of protein kinase B/Akt. In
contrast, antibody-induced blockade of GM3 func-
tion increases only threonine-308 phosphorylation
of ganglioside-de®cient cells. Whereas blockade of
phosphoinositide 3-OH kinase function suppresses
threonine-308 phosphorylation, it neither inhibits
serine-473 phosphorylation nor triggers apoptosis.
These data suggest that ganglioside depletion
modulates cell survival primarily through protein
kinase B/Akt stimulation by a pathway that does
not require phosphoinositide 3-OH kinase and epi-
dermal growth factor receptor signaling. Key
words: Bad/caspase-9/cell cycle/cyclin/®bronectin. J
Invest Dermatol 119:107±117, 2002
T
he binding of cell surface integrins to extracellular
matrices triggers a survival signal for normal cells
through activation of protein kinase B (PKB)/Akt,
and its downstream substrates (for review, Datta et
al, 1996). Phosphorylation of PKB/Akt is thought
to be regulated by integrin-linked kinase (ILK) in a phosphoi-
nositide 3-OH kinase (PI3-K)-dependent manner (Hannigan et
al, 1996; Persad et al, 2001). Normal, adherent cells undergo
apoptosis when detached from the extracellular matrix, which is
a form of apoptosis called anoikis (Frisch and Francis, 1994).
When epithelial cells are transformed by ras or src oncogenes,
however, or when PTEN function is inactivated, apoptosis is
suppressed, even when cells are detached from the matrix
(Frisch and Francis, 1994; Rytomaa et al, 2000). Ras protects
cells from apoptosis by binding to the catalytic p110 subunit of
PI3-K, leading to activation of PKB/Akt (Khwaja et al, 1997);
deletion of PTEN, a phosphatidylinositol triphosphate 3-
phosphatase, increases PI3-K expression and thus upregulates
PKB/Akt activity (Maehama and Dixon, 1999).
Gangliosides are sialylated glycosphingolipids that are located
on the outer lea¯et of the plasma membrane, and are thought
to participate in the regulation of several biologic processes (for
reviews, Bremer, 1994; Hakomori and Igarashi, 1995). In
keratinocytes and SCC12 cells, a squamous carcinoma cell line
derived from a squamous carcinoma cell on facial skin, speci®c
gangliosides affect proliferation, differentiation, and adhesion,
migration, and spreading on a ®bronectin matrix. For example,
the most prevalent ganglioside of keratinocytes, GM3, binds to
the epidermal growth factor (EGF) receptor (EGFR) and
inhibits proliferation through inhibiting phosphorylation of the
EGFR and its downstream signaling pathway components
(Wang et al, 2001a, >b). GT1b, a more highly sialylated
ganglioside of keratinocytes, binds directly to the a5 subunit of
the a5b1 receptor and, thus, inhibits adhesion, migration,
spreading of keratinocytes on a ®bronectin matrix in vitro (Paller
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et al, 1995; Sung et al, 1998; Wang et al, 2001c). GT1b also
induces apoptosis in keratinocytes1 and SCC12 cells (Wang et
al, 2001d) when cells are plated on a ®bronectin matrix, but
not polylysine.
Sialidases are glycohydrolases that release sialic acid residues from
the oligosaccharide segment of glycoproteins and glycolipids.
Sialidases are classi®ed based on their subcellular distribution into
at least four types (each type shows different catalytic and
immunologic properties): cytosolic, lysosomal matrix, lysosomal
membrane, and plasma membrane (Miyagi et al, 1999). Total
depletion of detectable plasma membrane gangliosides through
stable transfection of a hamster cytosolic sialidase gene into SCC12
cells preferentially cleaves gangliosides and dramatically increases
cell proliferation, particularly in response to EGF and transforming
growth factor-a (Wang et al, 2001a). Recently, Wada et al (1999)
has cloned a human plasma membrane sialidase that speci®cally
cleaves human plasma membrane gangliosides, and shows no
catalytic effect on glycoproteins or other glycolipids.
To understand better the modulatory effect of gangliosides on
cell survival and signaling pathway, we depleted totally the
gangliosides of SCC12 cells by stable transfection with human
plasma ganglioside-speci®c sialidase cDNA and blocked the
function of speci®c gangliosides with anti-ganglioside antibodies.
We have previously shown that these stably transfected cells
showed increased adherence, spreading and migration, speci®cally
on a ®bronectin matrix.2 We now ®nd that ganglioside depletion
induces resistance to apoptosis by a mechanism that involves
stimulation of ILK and PKB/Akt kinase activity and phosphoryl-
ation, but does not require PI3-K or EGFR activation.
MATERIALS AND METHODS
Antibodies and reagents Antibodies directed against GT1b and GM3
were obtained from Seikagaku (Tokyo, Japan). Antibodies directed
against PKB/Akt -phospho (p)-ser-473, PY-20, integrin b1, and cyclins
D1, D2, D3, and E were purchased from Transduction Laboratories
(Lexington, KY). Anti-cyclin-dependent kinase (cdk)4 antibody was
purchased from Pharmingen (San Diego, CA). Antibodies directly against
ILK, PKB/Akt, caspase-9, cdk2, Ser-p-112 Bad, Ser-p-136 Bad, and
inactivated glutathione-S-transferase (GST)-PKB/Akt were purchased
from Upstate Biotechnology (Lake Placid, NY). Anti-Bad antibodies
were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Antibody against PKB/Akt-p-thr-308, the PKB/Akt Kinase Assay Kit,
and the soluble cell-binding fragment of ®bronectin were purchased
from New England Biolabs (Beverly, MA). Fluorescein isothiocyanate-
Annexin V and propidium iodide were purchased from Molecular
Probes (Eugene, OR). Anti-phosphoserine, anti-phosphothreonine
antibodies, LY294002 were purchased from CalBiochem (La Jolla, CA).
Anti-bromodeoxyuridine (anti-BrdU) antibody was purchased from
Roche (Indianapolis, IN). [g-32P]adenosine triphosphate (3000 Ci per
mmol) was obtained from NEN Life Science (Boston, MA).
Gangliosides, antibodies directed against 9-O-acetyl GD3 or GD3, ethyl-
2,5-dihydroxycinnamate (EtDHC), and other chemical reagents were
purchased from Sigma unless indicated (St Louis, MO).
Cells and cell culture The human keratinocyte-derived squamous
carcinoma cell line SCC12F2 (SCC12 cells) (courtesy of Dr. James
Rheinwald, Boston, MA) was stably transfected with a human plasma
membrane ganglioside-speci®c sialidase cDNA (GenBank accession
number AB008185, courtesy of Dr. T. Miyagi, Tokyo, Japan; Wada et
al, 1999) in a pcDNA3 vector using lipofectamine reagent, following the
techniques described for the stable transfection of cytosolic hamster
sialidase cDNA (Wang et al, 2001a). Gene expression of the human
plasma membrane sialidase was demonstrated by sialidase activity
measurements and northern blotting with a digoxigenin-labeled 732 bp
sialidase cDNA probe and a digoxigenin-labeled 316 bp fragment of the
constitutively expressed human glyceraldehyde 3-phosphate
dehydrogenase cDNA as a control, using a DIG-high Prime DNA
Labeling and Detection Starter Kit II following manufacturer's
instructions (Roche Molecular Biochemicals, Indianapolis, IN). Effects
on ganglioside expression were delineated by examining cell lipid
extracts with thin layer chromatography immunostaining as previously
described for hamster cytosolic sialidase cDNA (Wang et al, 2001a, >b).
Pharmacologic addition of gangliosides, such as GM3or GT1b, is not
able to overcome the metabolic effect of the sialidase overexpression and
increase membrane ganglioside content, as occurs by addition of
ganglioside to normal keratinocytes and SCC12cells (Paller et al, 1993,
1995). SCC12cells were also stably transfected with the pcDNA3 vector
alone as a mock transfectant control (pcDNA). All cells were maintained
in Dulbecco's modi®ed Eagle's medium (DMEM)/F12(Gibco,
Rockville, MD) (1:1) medium with 10% fetal bovine serum in 5% CO2
at 37°C. Four SSIA cell lines and two mock-transfected cell lines were
studied, and results were consistent among transfected cell lines in each
experiment.
Effect of ganglioside depletion on cell survival The expression of
annexin V as an early indicator of apoptosis was assayed in parental
SCC12 cells, mock pcDNA transfected cells, ganglioside-depleted SSIA
cells, and SCC12 cells treated with anti-ganglioside antibodies. Cells
were grown in serum-free medium containing 10 mg per ml soluble cell-
binding fragment of ®bronectin for 24 h, then treated without or with
triggers of apoptosis, including deprivation of ®bronectin and serum for
96 h, exposure to 3.0 mM acetyl salicylic acid (ASA) for 72 h, or
exposure to 50 nM staurosporine for 24 h. For determining the effects of
anti-ganglioside antibodies, the SCC12 cells were treated with 10 mg per
ml anti-GT1b, anti-GD3, anti-GM3, or anti-9-O-acetylGD3 antibody in
DMEM/F12 medium containing 6 mg per ml bovine serum albumin for
30 min prior to exposure to the trigger of apoptosis. The expression of
annexin V was detected with ¯uorescein isothiocyanate-conjugated anti-
annexin V antibodies following manufacturer's instructions (Molecular
Probes, Eugene, ON). Necrotic cells were labeled with 1.5 mM
propidium iodide. Staining was monitored at 3 200 magni®cation
by immuno¯uorescence microscopy (Nikon Eclipse TE 300
immuno¯uorescence microscope linked to a computer with Neurolucida
software, MicroBrightField, Colchester, VT). The percentage of
apoptotic cells was determined as 100 3 apoptotic cells/total
healthy + apoptotic cells, and expressed as mean 6 SD. Cells from ®ve
high power ®elds (about 400±450 cells) were counted. Studies of
apoptosis were performed in triplicate at least four times.
To evaluate further the ability of gangliosides to cause DNA fragmen-
tation, cells were treated as above without or with triggers of apoptosis.
Genomic DNA was isolated and puri®ed from cells per manufacturer's
instruction (Qiagen, Carlsbad, CA). Five micrograms of total genomic
DNA was loaded on to a 1.5% agarose gel, electrophoresed, viewed
under ultraviolet light, and photographed as previously described (Wang
et al, 2001d).
Immunoprecipitations Total protein from the whole cell lysates
(500 mg) was mixed with 5 mg anti-Bad, anti-ILK, anti-PKB/Akt, anti-
caspase 9, anti-cyclin dependent kinase (cdk)2, or anti-cdk4 antibody,
followed by incubation with 10 mL of 50% protein A/agarose to
precipitate protein as previously described (Wang et al, 2001c). The
precipitated proteins were released from the beads by boiling in 30 mL
Laemmli buffer (Laemmli, 1970) for 10 min prior to loading on to
sodium dodecyl sulfate±polyacrylamide gel electrophoresis (SDS±PAGE)
mini-gels.
Immunoblotting Immunoblotting was carried out as described (Wang
et al, 2001c) using appropriate antibodies combined with an enhanced
chemiluminescence detection system (Amersham Pharmacia Biotech).
The following antibodies were used to detect separated proteins by
western blotting: anti-b1 integrin, anti-ILK, anti-PKB/Akt-p-ser-473,
anti-PKB/Akt-p-thr-308, anti-PKB/Akt, anti-phosphoserine, anti-
phosphothreonine, cyclins D1, D2, and D3, anti-cyclin E, anti-cdk2,
anti-cdk4, anti-Bad, anti-Bad-p-Ser-112, anti-Bad-p-Ser-136, and anti-
caspase 9 antibodies. Re-probing blots with more than one antibody was
performed up to twice (Wang et al, 2001d). Band density was quanti®ed
using the Storm 800 Fluorescence PhosphorImager. The 55 kDa
denatured heavy chain of IgG and, when detectable, the 25 kDa
denatured light chain of IgG were cut from the blots for ®gure
presentation.
Transfection of dominant negative (dn) mutant PKB/Akt cDNA
into the SSIA cells pUSEamp b-galactosidase (b-gal) (0.5 mg) (as a
colorimetric marker gene) and 4 mg of pUSEamp Akt1, dn-PKB/Akt
cDNA with functional inactivation of both Ser-473 and Thr-308
2Wang X, Sun P, Paller A: Ganglioside modulated keratinocyte
adhesion, spreading and migration by both integrin- and EGFR-mediated
signaling pathway. J Invest Dermatol 117:474, 2001 (abstr.)
1Sung CC, Gutierrez-Steinl C, Wrone-Smith T, Nickoloff BJ, Paller
AS: Induction of keratinocyte apoptosis on ®bronectin by ganglioside
GT1b. J Invest Dermatol 108:662, 1997 (abstr.)
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phosphorylation sites and containing a myc tag (Upstate Biotechnology,
Lake Placid, NY), were transiently cotransfected into SSIA cells by
mixing with Lipofectin reagent for 24 h (Gibco/BRL, Rockville, MD)
according to the manufacturer's guidelines. SSIA cells were also treated
for 24 h with 15 ml of Lipofectin reagent in serum-free medium in the
absence or presence of both pUSEamp b-gal and the empty pUSEamp
vector. The transfected cells were harvested 48 h later, and determined
to be > 95% cell viable using the trypan blue exclusion assay. Co-
transfected cells were washed by X-Gal staining buffer (77 mM
Na2HPO4, 23 mM NaH2PO4, 1.3 mM MgCl2, 3 mM K3Fe[CN]6,
3 mM K4Fe[CN]6, pH 7.3) twice, followed by staining for b-gal activity
with 1 mg per ml X-Gal (5-bromo-4-chloro-3-indolyl-b-D-galactoside)
in X-Gal staining buffer for 30 min at room temperature. Transfection
ef®ciency was determined by immuno¯uorescent staining with anti-myc
antibody for transfection of the dn-PKB/Akt, and detected with
¯uorescein isothiocyanate-conjugated secondary antibody. The effect of
disruption of PKB/Akt expression by gene introduction on reversing the
anti-apoptotic effect of ganglioside depletion cells was quanti®ed as
100 3 apoptotic cells per total cells with b-gal activity, and expressed as
mean 6 SD of the four SSIA cell lines. All studies were performed in at
least three separate experiments.
Modulation of ILK expression and activity by gene
transfection To assess further the role of ILK signal transduction in
the increased phosphorylation of PKB/Akt by ganglioside depletion,
SCC12 cells, mock transfectants, and SSIA cells were transiently
transfected with either His-V5-tagged wild-type ILK cDNA in a pcDNA
vector (GenBank accession number NM004517) or His-V5-tagged ILK
kinase de®cient cDNA in pcDNA (both a generous gift from Dr S.
Dedhar, Vancouver, Canada; Hannigan et al, 1996), using Lipofectin
reagent (Gibco) according to the manufacturer's instructions. Expression
of the cDNA and ef®ciency of transfection were assessed by staining the
cells with ¯uorescein isothiocyanate-labeled anti-V5 antibody. The
ef®ciency of gene transfection was also measured by comparing the ILK
expression and activity of transfected cells with parental cells. To assess
the function of ILK on cell survival, both wild-type ILK cDNA and
kinase dead (kd)-ILK cDNA were also cotransfected with pcDNA b-gal
into SSIA cells as described for dn-PKB/Akt cDNA transient
transfection, and cell survival was assessed based on cell morphology and
b-gal activity. Transfected cells were analyzed for cell viability by the
trypan blue exclusion viability assay to ensure > 95% viability.
Effect of dn-PKB/Akt on the anti-apoptotic function of
ganglioside depleted cells Cell morphology, rather than annexin V
or DNA ladder studies, was used to assess apoptosis to allow visualization
of b-gal expression as a marker of cell transfection, as transient
transfection led to only 40% transfection ef®ciency. After transient
transfection, the cells were cultured in serum-free DMEM/F12 with
10 mg per ml soluble cell-binding fragment of ®bronectin in the presence
or absence of either 3.0 mM ASA for 72 h, 50 nM staurosporine for
24 h, or without either ®bronectin or serum for 96 h. Cells showing
staining for b-gal activity were scored as normal or apoptotic on the
basis of cellular morphology (membrane blebbing, cytoplasmic and
nuclear condensation). Cells were viewed at 3 200 magni®cation with at
least ®ve high power ®elds counted (about 400±450 cells). The
percentage of apoptotic cells was determined as 100 3 apoptotic cells
with b-gal activity/total counted cells with b-gal activity, and expressed
as mean 6 SD. All experiments were performed at least three times in
triplicate.
Effect of inhibition of EGFR and PI3-K signaling pathways on
PKB/Akt-modulated, ganglioside-related cell survival SSIA cells
were switched to serum-free DMEM/F12 with 10 mg per ml soluble
cell-binding fragment ®bronectin and treated for 72 h with either 20 mM
LY294002, a speci®c inhibitor of PI-3 kinase, or with 20 mM EtDHC, a
speci®c inhibitor of EGFR-related tyrosine kinase. After treatment,
PKB/Akt was immunoprecipitated from the treated cells. The
immunoprecipitated protein was run on a 12% SDS±PAGE mini-gel,
transferred to PVDF membrane and the phosphorylation of serine (Ser)-
473 and threonine (Thr)-308 sites was examined by immunoblotting. In
other studies, SCC12 cells were treated for 30 min with anti-ganglioside
antibodies after starvation of serum, EGF, and ®bronectin for 18 h. After
removal of the anti-ganglioside antibodies, cells were stimulated with
10 mg per ml soluble cell-binding fragment ®bronectin for 24 h in the
presence or absence of 40 mM LY294002 or 35 mM EtDHC. ILK and
PKB/Akt were immunoprecipitated from the treated cells using anti-ILK
and anti-PKB/Akt antibodies, respectively. The phosphorylation of ILK
was detected by anti-phosphoserine and anti-phosphothreonine
antibodies, and of PKB/Akt with anti-PKB/Akt-p-thr-308 and anti-
PKB/Akt-p-ser-473 antibodies. In addition, cells treated as described
above with the LY294002 anti-PI3-K inhibitor, followed by induction
of apoptosis with 50 nM staurosporine, and were stained with annexin V
as previously described to assess if inhibition of this pathway could
trigger apoptosis.
Kinase assays ILK kinase activity was determined in cell extracts by
immunoprecipitation as described previously (Persad et al, 2000). Myelin
basic protein (MBP) was used as substrates for ILK activity in the
presence of 5 mCi [g-32P]adenosine triphosphate (3000 Ci per mmol) for
20 min at 30°C, and the radiolabeled phosphoproteins stimulated by the
immunoprecipitated ILK were electrophoresed on 12% SDS±PAGE gels
(Wang et al, 2001d). Similarly, ILK kinase activity was determined by
incubation with 1 mg GST-PKB/Akt per ml for 30 min at 37°C,
running the product on a 10% SDS±PAGE gel and detection of
phosphorylated PKB/Akt with anti-p-ser-473 PKB/Akt or anti-p-thr-
308 PKB/Akt antibody. For PKB/Akt kinase assays, cells were lysed
with PKB/Akt lysis buffer [20 mM Tris±HCl, pH 7.5, 150 mM NaCl,
1 mM ethylenediamine tetraacetic acid, 1 mM ethyleneglycol-bis-(b-
aminoethylether)-N,N,N¢,N¢-tetraacetic acid, 1% Triton X-100, 2.5 mM
sodium pyrophosphate, 1 mM glycerophosphate, 1 mM Na3VO4, 1 mg
leupeptin per ml, and 1 mM phenylmethylsulfonyl ¯uoride] as described
(Persad et al, 2000). Equivalent amounts of PKB/Akt were
immunoprecipitated by anti-PKB/Akt antibody prebound to protein A/
agarose beads, and kinase assays were carried out according to
manufacturer's instructions with the PKB/Akt Kinase Assay Kit using
glycogen synthetase kinase (GSK)-3 fusion protein as the substrate for
PKB/Akt (New England Biolabs). Phosphorylated proteins were
electrophoresed on 12% SDS±PAGE mini-gels and electrotransferred on
to PVDF membrane to detect phosphorylated GSK-3 using the p-GSK-
3 a/b (ser 21/9) antibody.
Cell cycle assays To monitor the effect of ganglioside depletion on
cell cycle progression, SCC12 cells, mock pcDNA transfectants, and
SSIA cells were synchronized in the G0 phase by serum, growth factor,
Figure 1. Human ganglioside-speci®c sialidase cDNA
transfection increases the expression of cell sialidase and
endogenously depletes SCC12 cell ganglioside. Ganglioside-speci®c
human plasma membrane sialidase cDNA was transfected into SCC12
cells, as described in Materials and Methods. (A) Positive transfectants were
further con®rmed by northern analysis of sialidase gene expression as
described. (B) Gangliosides were extracted from SCC12, mock clone
(pcDNA), and four sialidase cDNA transfected positive clones, and
analyzed by thin layer chromatography immunostaining as described
previously (Wang et al, 2001b). The ®rst lane shows ganglioside standards
of GM3, GM2, GM1, GD3, and GT1b. As expected, SCC12 cells and
the pcDNA-transfected cells both showed the expected doublet of GM3,
and additional bands of 9-O-acetyl GD3, GD3, and GT1b as we have
described. No ganglioside was detected in any of the lanes of sialidase-
transfected cell clones.
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and ®bronectin starvation for 18 h. Cell cycle progress was monitored by
BrdU incorporation as previously described (Wang et al, 2001d). To
determine the effect of ganglioside depletion on cyclin expression,
SCC12 cells, mock-transfected pcDNA cells, and SSIA cells were grown
as described above in 25 cm2 ¯asks until 80% con¯uent. Cells were then
switched to serum-free medium for 18 h, and subsequently incubated for
an additional 24 h in serum-free DMEM/F12 medium containing 10 mg
per ml soluble cell-binding fragment of ®bronectin. Cdk2 or cdk4 was
immunoprecipitated from equal amounts of whole cell lysate. The
immunoprecipitates were applied on to 12% SDS±PAGE mini-gels, and
the protein was transferred to PVDF membrane. Equal loading of cdk4
and cdk2 was determined with anti-cdk4 or anti-cdk2 antibody. The
blots were then washed and re-probed with anti-cyclin D1 or anti-cyclin
E antibody to detect the expression of G1 phase related cyclins.
Statistical analysis All data were analyzed statistically by Student's t
test, with p < 0.05 considered signi®cant.
RESULTS
Sialidase cDNA transfection increases the expression of cell
sialidase and endogenously depletes SCC12 cell
gangliosides Thirty-six clones were isolated by sialidase
activity analysis, and of these four were chosen for further
characterization and veri®cation of expression of the sialidase by
northern assay. The SCC12 cells stably transfected with the human
plasma membrane ganglioside-speci®c sialidase cDNA (``SSIA
cells'' SSIA3, SSIA6, SSIA12, and SSIA25) showed a 3.1±4.3-
fold increase in sialidase mRNA expression (Fig 1A) and an 8±10-
fold increase in levels of membrane sialidase activity in comparison
with parental and vector-control cell lines (data not shown).
Cytosolic sialidase activity was not increased. Plasma membrane
gangliosides were not detectable in any of the SSIA cell lines
(Fig 1B). Although demonstrated previously by Wada et al (1999),
we have con®rmed the lack of effect on sialylation of glycoproteins
by lectin analysis with peanut agglutinin, Maackia amurensis
agglutinin, and Sambucus nigra agglutinin lectins (data not shown)
(Wang et al, 2001a).
Ganglioside depletion prevents cell apoptosis As shown by
immuno¯uorescent annexin V staining assays (Fig 2A±G) and
DNA laddering (data not shown), ganglioside depletion by stable
transfection with human ganglioside-speci®c sialidase cDNA
prevented induction of apoptosis in all four SSIA cell lines, even
when apoptosis was stimulated by both ®bronectin and serum
deprivation (Fig 2D,G), ASA (Fig 2G), or staurosporine
(Fig 2F,G). Apoptosis was easily induced in the parental SCC12
cells (Fig 2C,E,G) and mock transfectants (Fig 2G). When the
SCC12 cells were treated with various anti-ganglioside antibodies,
only the anti-GT1b antibody caused the SCC12 cells to resist
apoptosis after exposure to triggers of apoptosis in comparison with
Figure 2. Ganglioside depletion protects SCC12 cells from
apoptosis. SCC12 cells (A, C, E), SCC12 cells depleted endogenously
of ganglioside by overexpression of human plasma membrane-speci®c,
ganglioside-speci®c sialidase cDNA (SSIA cells) (B, D, F), and SCC12
cells transfected with the pcDNA vector only (mock transfectants) (not
shown) were suspended in serum-free medium containing 10 mg per ml
soluble cell-binding fragment of ®bronectin. In another experiment,
SCC12 cells were treated with 10 mg per ml a-GT1b, a-GD3, a-GM3,
or a-9-O-acetylGD3 antibody in DMEM/F12 medium containing 6 mg
bovine serum albumin per ml for 30 min prior to exposure to the trigger
of apoptosis (H). Apoptosis was induced by treating cells with 3.0 mM
acetylsalicylic acid for 72 h in serum-free medium with ®bronectin (not
shown), 50 nM staurosporine for 24 h (E, F) in serum-free medium
with ®bronectin, or both serum and ®bronectin deprivation for 96 h (C,
D). Cells were then stained with ¯uorescein-conjugated Annexin V to
detect apoptosis. The percentage of apoptotic cells was determined as
100 3 apoptotic cells/total healthy + apoptotic cells, and expressed as
mean 6 standard deviation (G, H). Apoptotic cells show bright and
continuous labeling, whereas healthy, nonapoptotic cells show weak,
interrupted binding. All studies were performed in triplicate in at least
three separate experiments. SSIA6 cells are shown in (B, D, F). The
results of studies with SSIA3, SSIA12, and SSIA25 cells were virtually
identical, as quanti®ed in G. Scale bar: 25 mm; *p < 0.05; **p < 0.01;
***p < 0.001.
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untreated SCC12 cells and cells treated with other anti-ganglioside
antibodies (Fig 2H); there was an approximately 2-fold reduction
in apoptosis in anti-GT1b antibody-treated cells, regardless of the
stimulant of apoptosis.
Ganglioside depletion stimulates serine/threonine
phosphorylation of integrin b1, the phosphorylation of
ILK, and PKB/Akt phosphorylation at both Ser-473 and
Thr-308 sites Ganglioside depletion increased serine/threonine
phosphorylation of integrin b1 by 2.9±4.3-fold at the serine site
(Fig 3A, middle row) and by 2.1±3.2-fold at the threonine site
(Fig 3A, bottom row). Consistently, ganglioside depletion also
elevated ILK serine/threonine phosphorylation by 3.6±5.4-fold at
the serine site and by 1.7±3.2-fold at the threonine site (Fig 3B,
middle and bottom rows), and increased the phosphorylation of
PKB/Akt at both Ser-473 (3.7±5.6-fold) and Thr-308 (1.8±2.5-
fold) sites (Fig 3C, middle and bottom rows). Immunoblots of
whole cell lysates showed no difference in the expression of
integrin b1 (Fig 3A, top row), ILK (not shown), or PKB/Akt (not
shown) among the cell lines. Equal loading of immunoprecipitates
was con®rmed by probing a blot run in parallel with either anti-
ILK (Fig 3B, top row) or anti-PKB/Akt antibody (Fig 3C, top
row).
Ganglioside loss increases the activities of both ILK and
PKB/Akt The kinase activity of ILK was increased after
ganglioside loss by sialidase overexpression (Fig 4A), as detected
by phosphorylation of MBP (Fig 4A, top row). In studies with the
GST fusion protein GST-PKB/Akt as the substrate to test in vitro
ILK kinase activity, ganglioside loss activated PKB/Akt
phosphorylation at both Ser-473 and Thr-308 sites (Fig 4A,
third and bottom rows). Using serine phosphorylation of GSK-3 as
another measure of PKB/Akt activity (Delcommenne et al, 1998;
Persad et al, 2000), ganglioside depletion increased the PKB/Akt
kinase activity in SSIA3, SSIA6, SSIA12, and SSIA25 cell lines
(Fig 4B).
Figure 4. Ganglioside depletion activates ILK and PKB/Akt. Cells
were prepared as described in Materials and Methods. After stimulation
with ®bronectin, nondenatured ILK and PKB/Akt were then
immunoprecipitated with a-ILK antibody or a-PKB/Akt from whole
cell lysates. To determine the effect of ganglioside de®ciency on ILK
activity in vitro, MBP and GST-PKB/Akt recombinant protein were
tested as substrates for the activated ILK. The ILK immunoprecipitates
were mixed with MBP in the presence of [g-32P] adenosine triphosphate,
and radioactivity was detected by electrophoresis (A, top row). The ILK
immunoprecipitates were also reacted with recombinant GST-PKB/Akt,
the product was applied to a 10% SDS±PAGE mini-gel, and protein was
transferred to PVDF membrane. Equal loading of recombinant GST-
PKB/Akt protein was veri®ed by western blotting with a-PKB/Akt
antibody and enhanced chemiluminescence detection (A, second row).
Phosphorylation of the Ser-473 site was detected with speci®c a-PKB/
Akt-ser-p-473 antibody (A, third row) and of the Thr-308 site with a-
PKB/Akt-thr-p-308 antibody (A, bottom row). The kinase activity of
PKB/Akt was determined using GSK-3 as a substrate (B).
Immunoprecipitated PKB/Akt was mixed with the GSK-3 fusion
protein (1 mg per assay). The amount of loaded GSK-3 was detected by
immunoblotting with a-GSK-3 antibody and chemiluminescence (B, top
row); the effect on serine phosphorylation of the GSK-3 was determined
by reprobing the membranes with a-GSK-3-p-Ser-21/9 antibody (B,
bottom row).
Figure 3. Ganglioside depletion increases the serine/threonine
phosphorylation of integrin b1 and ILK, and the phosphorylation
of PKB/Akt at both Thr-308 and Ser-473 sites. SSIA, mock
transfectant (pcDNA), and parental SCC12 cells were starved of serum,
EGF, and ®bronectin, then stimulated with 10 mg per ml soluble cell-
binding fragment of ®bronectin in serum-free medium for 24 h as
described in Materials and Methods. Expression of integrin b1 (A, top
row), ILK (not shown) and PKB/Akt (not shown) was detected by
immunoblotting using 10±15 mg of total protein from whole cell lysate.
Phosphorylation of serine and threonine sites of integrin b1 was detected
with a-phosphoserine (A, middle row) and a-phosphothreonine (A,
bottom row) by applying 15 mg total protein from whole cell lysate.
Phosphorylation of ILK and PKB/Akt was detected using
immunoprecipitated ILK or PKB/Akt and immunoblotting. Equal
loading and the purity of immunoprecipitated ILK and PKB/Akt protein
was veri®ed by immunostaining the precipitates with a-ILK (B, top
row) or a-PKB/Akt (C, top row) antibody on blots run in parallel. The
phosphorylation of ILK was determined with a-phosphoserine (B,
middle row), and the same blot was then reprobed with a-
phosphothreonine (B, bottom row). The phosphorylation of PKB/Akt
was determined by probing the blots with a-PKB/Akt-phospho-ser-473
(C, middle row), and then reprobing the same blots with a-PKB/Akt-
phospho-thr-308 (C, bottom row).
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The resistance to apoptosis induced by ganglioside
depletion results primarily from the increased PKB/Akt
phosphorylation at Ser-473 site from loss of ganglioside
GT1b Blockade of GT1b function by anti-GT1b antibody-
stimulated ILK threonine phosphorylation by 2.3-fold and serine
phosphorylation by 2.4-fold. In contrast, blockade of the function
of other SCC12 cell gangliosides, GM3, GD3, or 9-O-acetyl GD3,
by speci®c anti-ganglioside antibodies had no effect on ILK
phosphorylation (Fig 5A). Blockade of GT1b function with anti-
GT1b antibody also increased PKB/Akt phosphorylation at its Ser-
473 site by 3.6-fold (Fig 5B, lane 2), but had no effect on Thr-308
phosphorylation. Blockade of GM3 with anti-GM3 antibody
increased phosphorylation of the Thr-308 site of PKB/Akt by
almost 2-fold (Fig 5B, lane 5), but had no effect on the Ser-473
site. Antibodies directed against 9-O-acetyl GD3 or GD3 did not
affect either ILK or PKB/Akt phosphorylation (Fig 5, lanes 3 and
4). Thus, the increased resistance to apoptosis induced by
ganglioside depletion is associated primarily with blockade of
GT1b function and PKB/Akt phosphorylation at Ser-473.
SSIA cells that express either dn-PKB/Akt or kd-ILK lose
their resistance to apoptosis The mean transient transfection
ef®ciency for dn-PKB/Akt in the four SSIA cell lines was 39% and
for dn-ILK was 42.4%, and the assumption was made that cells
expressing the dn-PKB/Akt or the ILK cDNA were cotransfected
with b-gal. Because the majority of cells were not transfected, cell
morphology and correlation with transfection status (e.g.,
concurrent b-gal staining) were used to determine the effect of
blockade of ILK/PKB/Akt function. The apoptotic cells showed
abnormal cell morphology, particularly membrane blebbing, and
cytoplasmic and nuclear condensation. Expression of dn-PKB/Akt
blocked the anti-apoptotic effect of ganglioside depletion in all four
SSIA cells, leading to a mean percentage of apoptotic cells of 50.8%
of cells showing b-gal staining/transfected with the dn-PKB/Akt
induced by both ®bronectin and serum deprivation, 63.3% of
transfected cells induced by ASA, and 74.2% of transfected cells
induced by staurosporine (Fig 6A). Consistently, transient
Figure 6. Resistance to apoptosis by ganglioside depletion
requires intact ILK and PKB/Akt signaling. SSIA cells were
transiently cotransfected with pUSEamp b-gal cDNA and dn-PKB/Akt
cDNA (or its pUSEamp vector) (A), or with pcDNA b-gal cDNA and
kd-ILK cDNA, wild-type ILK cDNA, or the ILK cDNA vector control
(B).Forty-eight hours after transfection, cells were stained with X-Gal,
viewed by light microscopy, and the percentage of cells showing both b-
gal staining and apoptosis by morphology were calculated as a percentage
of the total number of b-gal stained cells. Transient transfection with dn-
PKB (A, lane 3) or kd-ILK (B, lane 4) led to the induction of apoptosis
(p < 0.01) and, even more so, in the presence of ®bronectin and serum,
acetylsalicylic acid, or staurosporine (p < 0.001). In comparison, SSIA
cells (®rst lane of each set of conditions in A, B), and SSIA cells
transfected with vector controls (second lane of each set of conditions)
resisted apoptosis. Wild-type ILK expression (B, lane 3) showed an
enhanced anti-apoptotic function when compared with SSIA and mock-
transfected cells. Shown in A and B are the mean values of studies with
transfection of each of the four SSIA cell lines and one vector control
cell line. *p < 0.05; **p < 0.01; ***p < 0.001.
Figure 5. Increases in ILK and PKB/Akt phosphorylation at Ser-
473 are affected by depletion of GT1b. After growth to 70%
con¯uence in DMEM/F12 with 10% fetal bovine serum, SCC12 cells
were transferred to serum-free DMEM/F12 without growth factor or
®bronectin for 18 h. Cells were then incubated with a-ganglioside
antibody in the serum-free DMEM/F12 containing 6 mg bovine serum
albumin per ml for 30 min and then stimulated with 10 mg per ml
soluble cell-binding fragment of ®bronectin for an additional 24 h. ILK
and PKB/Akt were immunoprecipitated from cells. Equal amount of
immunoprecipitate were applied to a 12% SDS±PAGE mini-gel and
protein loading was detected by a-ILK (A, top row) or a-PKB/Akt (B,
top row) antibody. The phosphorylation of ILK (A, middle and bottom
rows) and PKB/Akt (B, middle and bottom rows) was detected as
described in Fig 3.
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transfection of ILK rendered ``kinase dead'' by an E359K point
mutation into the SSIA cells allowed induction of apoptosis
(Fig 6B). In these cells the lack of ILK kinase activity was veri®ed
by failure to show phosphorylation of the MBP substrate (not
shown). In contrast, overexpression of wild-type ILK cDNA into
SSIA cells maintained the anti-apoptotic effect of ganglioside-
depletion (Fig 6B). Transient transfection of kd-ILK decreased
PKB/Akt phosphorylation at Ser-473 by 2.2-fold, whereas
overexpression of wild-type ILK increased the phosphorylation of
PKB/Akt at the Ser-473 site by 3.9-fold. Gene modulation of ILK
expression had no effect on Thr-308 phosphorylation (not shown).
Blockade of EGFR and PI3-K signaling in SSIA cells in the
presence of ®bronectin decreases PKB/Akt phosphorylation
only at the Thr-308 site and is unable to overcome PKB/Akt
activation It has previously been shown that both SCC12 cell
EGFR and PI3-K are able to be activated in the presence of the
soluble cell-binding fragment of ®bronectin and absence of both
serum and growth factor.2 In addition, previous studies with
SCC12 cells stably transfected with hamster sialidase cDNA (Wang
et al, 2001a) and human plasma membrane ganglioside-speci®c
sialidase cDNA (unpublished data) showed markedly increased
proliferation, especially in response to ligands of the EGFR, and
increased activation of the EGFR and its downstream signal
transduction pathway components. As the biologic behavior of the
ganglioside-speci®c human sialidase transfected SCC12 cells re-
sembles closely that of SCC12 cells transfected with the hamster
sialidase, it was thought imperative to investigate the possible role
of the EGFR and PI3-K signaling pathways in the stimulation by
ganglioside depletion of PKB/Akt phosphorylation at speci®c
phosphorylation sites. PKB/Akt phosphorylation was not
detectable when SCC12 cells were grown in serum-free medium
without the presence of either ®bronectin or EGF (not shown), and
was barely detectable when SSIA cells were grown under these
conditions (Fig 7A, middle and bottom rows, lane 1). Exposure to
Figure 7. Inhibitors of EGFR and PI3 kinase decrease PKB/Akt phosphorylation at the Thr-308 site when cells are exposed to
®bronectin, but have no effect on ILK phosphorylation or phosphorylation of PKB/Akt at its Ser-473 site. (A)SSIA cells were incubated
with 20 mM LY294002 or EtDHC in the presence of 10 mg per ml soluble cell-binding fragment ®bronectin. In other studies, the SCC12 cells were
incubated with a-ganglioside antibodies for 30 min after starvation of serum, EGF, and ®bronectin for 18 h. The cells were then stimulated with 10 mg
per ml soluble cell-binding fragment ®bronectin in the presence or absence of 40 mM of LY294002 for another 24 h. PKB/Akt or ILK was
immunoprecipitated with a-PKB/Akt or a-ILK antibody, respectively, and the immunoprecipitate was applied to a 12% SDS±PAGE mini-gel. PKB/
Akt phosphorylation (B) and ILK phosphorylation (C) was detected as described in Fig 3. Equal loading and purity of immunoprecipitates was
con®rmed by immunostaining of the blot with a-PKB/Akt antibody (A, B, top rows) or a-ILK antibody (C, top row).
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®bronectin promotes PKB/Akt phosphorylation of both SSIA cells
(Fig 7A, middle and bottom rows, lane 2) and parental SCC12 cells
(Fig 7B, middle and bottom rows, lane 1). Inhibitors of EGFR-
related tyrosine kinase (EtDHC) and PI3 kinase (LY294002)
blocked the phosphorylation of PKB/Akt at the Thr-308 site rather
than at the Ser-473 site when SSIA cells were grown in serum-free,
growth factor-free medium, but containing ®bronectin (Fig 7A,
middle and bottom rows, lanes 3 and 4). When parental SCC12
cells were grown in the presence of LY294002 (Fig 7B, middle
and bottom rows, lane 2) and ®bronectin, or EtDHC and
®bronectin (not shown), only Thr-308 phosphorylation was
decreased. Phosphorylation of PKB/Akt at Ser-473 was increased
by anti-GT1b antibody and unaffected by PI3-K inhibition
(Fig 7B, bottom row, lanes 3 and 4), or by inhibition of EGFR-
related kinase (not shown); treatment of the SCC12 cells with
LY294002 inhibited phosphorylation of PKB/Akt at its Thr-308
site in the presence of all anti-ganglioside antibodies, including
anti-GT1b (Fig 7B, middle row, lanes 2, 4, 6, and 8). Anti-GM3
and anti-9-O-acetylGD3 antibodies showed no effect on PKB/Akt
phosphorylation at the Ser-473 site. Consistently, treatment with
anti-GT1b antibody, but not with anti-GM3 and anti-9-O-
acetylGD3 antibody, increased serine/threonine phosphorylation
of ILK (Fig 7C, middle and bottom rows, lane 3). Treatment with
LY294002 did not diminish the increase in ILK phosphorylation
induced by anti-GT1b antibody (Fig 7C, middle and bottom rows,
lane 4). To corroborate the lack of effect of inhibition of PI3-K
signaling on phosphorylation of PKB/Akt Ser-473 and failure to
trigger apoptosis, cells treated with LY294002 were evaluated by
annexin V staining for apoptosis with and without staurosporine.
Fewer than 10% of SSIA became apoptotic in the presence of
staurosporine, regardless of the presence of LY294002, whereas
65% of the SCC12 cells became apoptotic after exposure to
staurosporine (p < 0.001).
Ganglioside depletion protects cell from apoptosis by
stimulation of Bad phosphorylation and inactivation of
Figure 8. Ganglioside depletion prevents cell apoptosis by
phosphorylating Bad and inactivating procaspase-9. SCC12 cells,
pcDNA mock transfectants, and sialidase gene-transfected SCC12
cells (SSIA) were grown in serum-free medium in the presence of
®bronectin. Equal amount of cell lysates were incubated with either
rabbit a-Bad polyclonal antibody or a-caspase 9 antibodies to
immunoprecipitate Bad and caspase 9. The immunoprecipitates were
applied to a 12% SDS±PAGE mini-gel and transferred to PVDF
membrane. The Bad immunoprecipitates were probed with mouse a-
Bad monoclonal antibody (A, top row), and phosphorylation of Bad was
detected by mouse a-Bad-phospho-Ser-112 (A, middle row) or mouse
a-Bad-phospho-Ser-136 (A, bottom row) antibody using three blots run
in parallel. The caspase 9 immunoprecipitates were probed with a-
caspase 9 antibody (B, top row) and the phosphorylation of caspase 9
was determined by a-phosphoserine antibody (B, lower row) using two
blots run in parallel. Antibody binding was detected by enhanced
chemiluminescence.
Figure 9. Ganglioside depletion stimulates cell cycle progression
by increasing the expression of cyclins D and E. SCC12 cells,
mock pcDNA transfectants, and SSIA cells were synchronized in G0
phase by starvation of serum, EGF, and ®bronectin for 18 h. Cells were
trypsinized, plated on to 96-well plates precoated with or without 5 mg
per cm2 ®bronectin or 10 mg per cm2 poly L-lysine, and grown in
serum-free medium containing 10 mM BrdU for 24 h (A). BrdU
incorporation was stopped by washing cells with cold PBS. Cells were
then stained with a-BrdU monoclonal antibody, and incorporation was
detected with alkaline phosphatase-conjugated a-mouse IgG. To
determine the effect of ganglioside depletion on the expression of G0
phase-related cyclins, SCC12 cells, mock-transfected pcDNA cells, and
SSIA cells were grown in 25 cm2 ¯asks until 80% con¯uent. Cells were
then switched to serum-, EGF- and ®bronectin-free medium for 18 h,
and subsequently stimulated for an additional 24 h in serum-free
DMEM/F12 medium containing 10 mg per ml soluble cell-binding
fragment of ®bronectin. Cdk2 or cdk4 was immunoprecipitated from
equal amounts of cell lysate. The immunoprecipitates were applied to
12% SDS±PAGE mini-gels, and the protein was transferred to PVDF
membrane. Equal loading of cdk4 and ckd2 was determined with a-
cdk4 (B, top row) or a-cdk2 (B, third row) antibody. The blots were
then washed and re-probed with a-cyclin D1 (B, second row) and a-
cyclin E (B, bottom row) antibody to determine changes in cyclin
expression.
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caspase-9 PKB/Akt activation inhibits cells apoptosis by
inactivating downstream apoptotic factors, such as Bad and
caspase-9 (Datta et al, 1997; Kops et al, 1999). Ganglioside
depletion (Fig 8A, middle and bottom rows, lanes 3±4) or
blockade of GT1b function by anti-GT1b antibody (not shown)
signi®cantly increased Bad phosphorylation at both Ser-112 site by
1.9±3.2-fold and Ser-136 site by 2.5±2.9-fold. Ganglioside
depletion (Fig 8B, bottom row, lanes 3 and 4) or blockade of
GT1b (not shown) also increased caspase-9 serine phosphorylation
by 2.1±3.8-fold, thereby inhibiting procaspase-9 activation.
Ganglioside depletion promotes cell cycle progression BrdU
incorporation of SCC12 cells in serum-free medium plated on a
®bronectin matrix, but not on poly L-lysine, was signi®cantly
increased by depletion of gangliosides (Fig 9A). Ganglioside
depletion also increased expression of both cyclin D1 associated
with cdk4 by 2.3±3.5-fold (Fig 9B, second row, lane 3 showing
3.5-fold increase) and cyclin E associated with cdk2 by 1.8±2.4-fold
(Fig 9B, bottom row showing 2.2-fold increase), respectively,
when compared with parental SCC12 cells and mock-transfected
cells. Cyclins D2 and D3 were undetectable in SCC12 cells (not
shown). The expression of cyclins D1 or E was virtually
undetectable when cells were grown in the absence of
®bronectin (G0 phase) (Fig 9B, lane 4). Treatment of cells with
anti-ganglioside GT1b antibody similarly increased BrdU
incorporation and expression of cyclins D1 and E; whereas
blocking of GM3 or 9-O-acetyl GD3 with antibodies had no
effect on BrdU incorporation or the expression of the cyclins (not
shown).
DISCUSSION
Cell±matrix interactions via integrins are able to activate intra-
cellular signaling pathways that lead to increased cell survival,
proliferation, differentiation, and migration. Three key
components that regulate integrin-mediated cell survival are
PKB/Akt and its upstream effectors, ILK and PI3-K (Hannigan et
al, 1996; Khwaja et al, 1997; Delcommenne et al, 1998). The
regulation of PKB/Akt activity is complex, and involves phos-
phorylation of two highly conserved sites, Thr-308 in the kinase
core and Ser-473 in the carboxy terminal region (Downward,
1998; Toker and Newton, 2000). Phosphoinositide-dependent
kinase (PDK)-1 has been shown to phosphorylate Thr-308; the
Ser-473 can be activated both by PDK-1 in the presence of protein
kinase C-related kinase-2 peptide (Balendran et al, 1999; Toker and
Newton, 2000) and by ILK (Delcommenne et al, 1998; Persad et al,
2000).
ILK is an intracellular serine/threonine protein kinase that
interacts with the integrin b1 cytoplasmic domain via its carboxyl
terminus (Hannigan et al, 1996). Although the role of the
interaction of ILK with b1 integrin in signal transduction is
unknown, the binding of ILK to b1 integrin is thought to be
required for localization of ILK to focal adhesion plaques (Li et al,
1999). Overexpression of ILK in mammary epithelial cells and
intestinal epithelial cells encourages anchorage-independent cell
growth, cell cycle progression (Radeva et al, 1997), and
tumorigenicity in nude mice (Wu et al, 1998). Conversely,
inhibition of ILK phosphorylation provides a signal for apoptosis.
The level of PI3 also in¯uences the activity of ILK (Franke et al,
1995; Delcommenne et al, 1998), so that inactivation of a PI3
phosphatase such as PTEN leads to activation of ILK. Activation of
PKB/Akt, in turn, is able to phosphorylate the pro-apoptotic factor
Bad (Datta et al, 1997; del Peso et al, 1997), inactivate caspase-9
(Cardone et al, 1998), and repress the forkhead transcription factor
(Brunet et al, 1999; Kops et al, 1999), leading to protection from
apoptosis.
Using a keratinocyte-derived squamous carcinoma cell line, it
was demonstrated that total depletion of gangliosides through stable
transfection of a human plasma membrane ganglioside-speci®c
sialidase leads to pro-survival signaling, when cells are exposed to
®bronectin, and cellular resistance to apoptosis; this occurred
whether the stimulus is deprivation of serum and ®bronectin,
exposure to acetylsalicylic acid, or exposure to staurosporine. The
mechanism of the resistance to apoptosis involves increased serine/
threonine phosphorylation of ILK, and phosphorylation of both the
Ser-473 and the Thr-308 sites of PKB/Akt; transfection of a
dominant negative mutant of PKB/Akt and a kinase de®cient
mutant of ILK into the ganglioside-depleted SSIA cells reversed the
resistance, rendering the cells susceptible to apoptosis (Fig 10).
Several keratinocyte-derived cell lines were considered in choosing
the cell line for stable transfection of the sialidase gene. The SCC12
cell line was selected based on its identical responses to gangliosides
seen in keratinocytes with respect to proliferation, adhesion, and
migration on ®bronectin, apoptosis, and EGFR and FAK signal
transduction. As in SCC12 cells, ganglioside GM3 inhibits the
proliferation of undifferentiated cultured keratinocytes (Paller et al,
1993) by a mechanism that involves decreased phosphorylation of
the EGFR.3 GT1b inhibits keratinocyte adhesion and migration on
a ®bronectin matrix (Paller et al, 1995) by a mechanism that
involves inhibition of FAK phosphorylation, and triggers kerati-
nocyte apoptosis, speci®cally on a ®bronectin matrix. 1 In contrast,
other keratinocyte-derived cell lines do not show normal responses
to gangliosides. For example, SCC13 and HaCaT cell lines show
sparse expression of surface integrins, including a5b1, and their
migration on ®bronectin is not inhibited by GT1b (Sung et al,
1998); HaCaT cells become sensitive to the inhibition by
®bronectin when a5b1 is induced by transforming growth
factor-b. Studies of ganglioside content have also shown similar
expression in keratinocytes and SCC12 cells of GM3 (64±65%),
GD3 (10±14%), and GT1b (7%). Keratinocytes, but not SCC12
cells, show expression of GM1 (a ganglioside that does not affect
Figure 10. Model of the pathways affected by ganglioside
depletion. Absence of gangliosides, and particularly GT1b, allows
activation of PKB/Akt signaling through phosphorylation of its Ser-473
residue, phosphorylating Bad and thereby inhibiting procaspase-9
conversion to caspase-9 and promoting survival on a ®bronectin matrix.
Although depletion of gangliosides, especially, GM3, is known to
promote phosphorylation of the EGFR and PI3-K (Wang et al, 2001b),
the activation of PI3-K does not impact on the survival signal of cells on
a ®bronectin matrix.
3Paller AS, Arnsmeier SL, Bryk D, Bremer EG: Inhibition of
phosphorylation of the epidermal growth factor receptor by ganglioside
GM3. J Invest Dermatol 104:592, 1995 (abstr.)
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biologic behavior when added to cells), whereas SCC12 cells show
expression of an acetylated form of GD3, 9-O-acetylGD3, which is
not expressed in keratinocytes (Wang et al, 2001c). SCC12 cells are
able to differentiate and form rafts in lifted cultures that resemble
those of normal keratinocytes (unpublished data), and form either
squamous cysts (Rheinwald and Beckett, 1981) or small, slow-
growing squamous cell carcinomas when inoculated into the skin of
immunode®cient mice. Although the SCC12 line was selected to
study the effects of ganglioside depletion on survival and signaling,
it should be stressed that the genetic defect underlying the
transformation of these cells is unknown.
In an attempt to determine which of the four detectable
gangliosides of SCC12 cells mediates the effect on cell survival,
parental SCC12 cells were treated with anti-ganglioside antibodies,
and the ability of ASA, staurosporine, and deprivation of both
serum and ®bronectin to trigger apoptosis was assessed. Anti-GT1b
antibody led to signi®cant resistance to apoptosis, but not total
resistance; cells treated with anti-GD3, anti-GM3, or anti-9-O-
acetyl-GD3 antibody became apoptotic in response to ASA,
staurosporine, and deprivation of both serum and ®bronectin to
the same degree as the parental SCC12 cells. Anti-GT1b antibody
increased serine/threonine phosphorylation of ILK, and phos-
phorylation of the Ser-473 site of PKB/Akt, without affecting
phosphorylation of the Thr-308 site. Anti-GM3 antibody was able
to increase phosphorylation of the Thr-308 site, but not the Ser-
473 site, and did not affect apoptosis, suggesting the primary
importance of phosphorylation at the Ser-473, but not the Thr-308
site in the ganglioside-mediated modulation of epithelial cell
apoptosis. It has previously been demonstrated that GT1b is able to
induce apoptosis of keratinocytes1 and SCC12 cells (Wang et al,
2001d) grown in the presence of ®bronectin, but that GM3 has no
effect. Given the partial protection from apoptosis with anti-GT1b
antibody alone, however, and the near total protection with
depletion of all gangliosides, we suspect that activation of
phosphorylation of both Ser-473 and Thr-308 sites of PKB/Akt
is required for full resistance.
The ganglioside-depleted SSIA cells show several alterations in
biologic behavior. In addition to the increased adhesion to, and
migration and spreading on a ®bronectin matrix, and resistance to
apoptosis, SSIA cells proliferate more quickly than parental SCC12
cells. Although the hyperproliferation is consistent with the
demonstrated increase in cyclins and cell cycling, SSIA cells also
show increased phosphorylation of both EGFR and downstream
signaling components, including PI3-K (Wang et al, 2001a). These
®ndings are consistent with the known ability of gangliosides GM3
(Paller et al, 1993; Wang et al, 2001a) and GT1b (unpublished data)
to decrease keratinocyte proliferation by binding to the EGFR and
inhibiting receptor phosphorylation and downstream signaling,
including that of PI3-K. Given the known ability of PI3-K to
phosphorylate PKB/Akt, we considered the possibility that GT1b
depletion results in ILK and PKB/Akt activation through EGFR
and downstream PI3-K signaling. We examined the in¯uence of
blockade of PI3-K and EGFR tyrosine kinase activity in the
presence of ®bronectin on the ability of SSIA cells and anti-GT1b
antibody treatment of SCC12 cells to send the pro-survival signal
through ILK and the Ser-473 site of PKB/Akt. In the presence of
®bronectin but absence of growth factors, treatment with the
inhibitor LY294002 was unable to reverse the survival signal and
lead to apoptosis, even in the presence of staurosporine. Blockade
of PI3-K activity by either LY294002 or the inhibitor of EGFR-
related tyrosine kinase, EtDHC, decreased only the phosphoryl-
ation of the Thr-308 site of PKB/Akt, and was unable to suppress
phosphorylation of the Ser-473 site, regardless of whether the cells
were SSIA cells, parental SCC12 cells, or SCC12 cells treated with
anti-GT1b antibodies. The failure of blockade of this pathway to
affect the ganglioside-induced modulation of ILK or of PKB/Akt
activity at Ser-473 provides further evidence of a distinct ganglio-
side-mediated pathway through ILK and suggests that alterations in
PKB/Akt activity through ganglioside modulation may be able to
at least partially overcome PI3-K-mediated regulation of PKB/Akt
phosphorylation.
Ganglioside GT1b inhibits binding of keratinocytes and SCC12
cells to a ®bronectin matrix through binding directly to the a5
subunit of a5b1 (Wang et al, 2001c), and downregulating FAK
phosphorylation. The observed increase in b1 serine/threonine
phosphorylation of the SSIA cells, which parallels the increase in
serine/threonine phosphorylation of ILK, suggests both that GT1b
is able to modulate b1 phosphorylation and that b1 integrin may
serve as an upstream effector of ILK phosphorylation, distinct from
PI3-K. In previous studies, we have demonstrated only weak
binding of GT1b to b1 integrin directly, in contrast to its strong
interaction with a5 (Wang et al, 2001c). This led us to theorize that
the interaction of ganglioside with a5 in the presence of ®bronectin
brings about a conformational change in b1 integrin that modulates
ILK/PKB/Akt signaling. Other gangliosides of SCC12 cells are
either unable to bind a5 or b1 directly or, in the case of ganglioside
GD3, are able to bind a5 weakly and b1 not at all. GD3 is the only
other keratinocyte ganglioside that triggers SCC12 cell apoptosis
(Wang et al, 2001d). Whereas cell membrane initiated signaling
from GD3 is unknown, GD3 is thought to affect mitochondrial
pore transition directly (Kristal and Brown, 1999; Scorrano et al,
1999), and thereby affects mitochondrial cytochrome c release and
increase of caspase 9 activity. GD3 is unable to inhibit ILK or PKB/
Akt phosphorylation (Wang et al, 2001d), suggesting that the
interaction of GD3 in the presence of ®bronectin is insuf®cient to
trigger b1 integrin-mediated ILK signaling.
Tumors of epithelium and other tissues develop when PKB/
Akt is activated by mutations or overexpression of oncogenes
that provide constitutively a signal that normally is triggered by
integrins in contact with the extracellular matrix. Mutations of
the tumor suppressor gene PTEN lead to Cowden syndrome
(Myers et al, 1998), characterized by trichilemmomas, oral and
cutaneous papillomas, and carcinomas of the breast and thyroid,
but also sporadic neoplasms, such as melanoma (Guldberg et al,
1997), and cancers of the lungs (Kohno et al, 1998), brain,
breast, and prostate (Li et al, 1997). Ras expression in epithelial
cells results in resistance to apoptosis when detached from a
matrix, and a neoplastic phenotype, due to constitutive
activation of PI3-K and downstream PKB/Akt (Khwaja et al,
1997). In contrast, inhibition of PKB/Akt activation in
neoplastic cells has been shown to reverse the malignant
phenotype. Inhibition of either PI3-K or PKB/Akt abrogates
the protection against apoptosis conferred by the Ras oncogene
(Khwaja et al, 1997). Downmodulation of b1 integrin signaling
by anti-b1 function blocking antibody is able to revert the
malignant behavior of a human breast tumor cell line (T4-2)
and lead to growth arrest (Weaver et al, 1997). Direct inhibition
of ILK activity has also induced anoikis in anoikis-resistance
human breast cancer cell lines (Attwell et al, 2000). This study
provides evidence that activation of ganglioside-speci®c sialidase
provides another survival signal, mediated through the PKB/Akt
pathway, but without the requirement of PI3-K stimulation.
Although likely to be cell speci®c, ganglioside depletion could
provide another means by which cells are able to escape
apoptosis. Furthermore, a novel means for interrupting signaling
that constitutively activates PKB/Akt, and potentially reverses
the continuous cell cycling and proliferation of epithelial
malignant cells may be provided by: (i) modulation of
ganglioside activity through inhibition of ganglioside sialidase
activity; (ii) increased expression of glycosyltransferases that
upregulate the expression of pro-apoptotic gangliosides; or (iii)
direct addition of gangliosides to their speci®c cell targets.
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